Skip to main content

Table 1 Correlation between CTPS2 protein expression and clinicopathologic parameters of chronic lymphocytic leukemia (CLL) patients from Shandong Provincial Hospital CLL (SPHCLL) database

From: CTP synthase 2 predicts inferior survival and mediates DNA damage response via interacting with BRCA1 in chronic lymphocytic leukemia

Characteristics

No

CTPS2 expressiona

p value

Low

High

Age(years)

  < 60

33

16

17

0.994

  ≥ 60

35

17

18

 

Gender

 Male

44

22

22

0.885

 Female

29

14

15

 

WBC Count (*109/L)

  < 40

46

22

24

0.874

  ≥ 40

24

11

13

 

Rai stage

 Low risk

42

19

23

0.218

 High risk

14

4

10

 

Binet stage

 Stage A or B

38

17

21

0.448

 Stage C

15

5

10

 

IGHV mutation

 Mutated

17

12

5

0.035*

 Unmutated

6

1

5

 

ZAP 70

 Positive

4

1

3

0.661

 Negative

30

9

21

 

CD38

 Positive

4

2

2

0.529

 Negative

36

14

22

 

Serum LDH

 Normal

50

22

28

0.384

 Elevated

14

8

6

 

Serum β2-MG

    

 Normal

36

15

21

0.581

 Elevated

31

15

16

 

17p

 Normal

36

14

22

0.528

 Deletion

4

2

2

 

FISH

Favorable: normal,13q-, trisomy 12

23

10

13

0.038*

Unfavorable: 11q- and/ or 17p-

14

3

11

 
  1. Bold font indicates statistical significance
  2. WBC White blood cell; LDH Lactate dehydrogenase; β2-MG β2-microglobulin; HR Hazard ratio; CI Confidence interval
  3. aCut-off value was based on median mRNA expression level of CTPS2
  4. *p < 0.05